{"id":"W3154244221","doi":"10.1080/13696998.2021.1917139","title":"Cost-effectiveness of nivolumab in squamous and non-squamous non-small cell lung cancer in Canada and Sweden: an update with 5-year data","year":2021,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Medicine; Nivolumab; Docetaxel; Population; Clinical trial; Cost effectiveness; Quality-adjusted life year; Internal medicine; Oncology; Randomized controlled trial; Cost–benefit analysis; Demography; Cancer; Environmental health; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006502236,0.001043677,0.002106959,0.005752708,0.0007588027,0.003681024,0.002004723,0.001030428,0.002108223],"category_scores_gemma":[0.01793843,0.0005632038,0.005397456,0.01158969,0.0006523426,0.001065995,0.0009002811,0.00193241,0.0002235764],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.07627092,"about_ca_system_score_gemma":0.08025655,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9731618,"about_ca_topic_score_gemma":0.9726428,"domain_scores_codex":[0.996119,0.000792603,0.0003972929,0.0002496959,0.002028356,0.0004130921],"domain_scores_gemma":[0.9849488,0.002972363,0.001590283,0.0002470474,0.009505506,0.0007360372],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.006617877,0.0003083166,0.3597882,0.02334991,0.02600179,0.001022247,0.001204856,0.1097472,0.0004417534,0.00953371,0.09959779,0.3623862],"study_design_scores_gemma":[0.001621417,0.0006487534,0.7439255,0.02544515,0.02246053,0.001373669,0.002009872,0.04650449,0.001647444,0.004926453,0.1487879,0.0006488425],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.2843096,0.5724242,0.003570777,0.01048909,0.0007045796,0.000409366,0.1131797,0.0002005168,0.01471219],"genre_scores_gemma":[0.749009,0.1895847,0.004145601,0.001863827,0.0002319572,0.0003187773,0.0522928,0.0001289604,0.002424412],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.07627092,"threshold_uncertainty_score":0.5533869,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02007993074301333,"score_gpt":0.2834601182077676,"score_spread":0.2633801874647543,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}